Literature DB >> 28130099

Mathematical investigation of diabetically impaired ultradian oscillations in the glucose-insulin regulation.

B Huard1, A Bridgewater2, M Angelova3.   

Abstract

We study the effect of diabetic deficiencies on the production of an oscillatory ultradian regime using a deterministic nonlinear model which incorporates two physiological delays. It is shown that insulin resistance impairs the production of oscillations by dampening the ultradian cycles. Four strategies for restoring healthy regulation are explored. Through the introduction of an instantaneous glucose-dependent insulin response, explicit conditions for the existence of periodic solutions in the linearised model are formulated, significantly reducing the complexity of identifying an oscillatory regime. The model is thus shown to be suitable for representing the effect of diabetes on the oscillatory regulation and for investigating pathways to reinstating a physiological healthy regime.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Delay differential equations; Diabetes; Four healthy regulation strategies; Impaired ultradian rhythms; Stability analysis

Mesh:

Substances:

Year:  2017        PMID: 28130099     DOI: 10.1016/j.jtbi.2017.01.039

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  3 in total

1.  Blood glucose concentration control for type 1 diabetic patients: a multiple-model strategy.

Authors:  Yazdan Batmani; Shadi Khodakaramzadeh
Journal:  IET Syst Biol       Date:  2020-02       Impact factor: 1.615

2.  Multi-Timescale Rhythmicity of Blood Glucose and Insulin Delivery Reveals Key Advantages of Hybrid Closed Loop Therapy.

Authors:  Azure D Grant; Dana M Lewis; Lance J Kriegsfeld
Journal:  J Diabetes Sci Technol       Date:  2021-03-10

3.  Examining Type 1 Diabetes Mathematical Models Using Experimental Data.

Authors:  Hannah Al Ali; Alireza Daneshkhah; Abdesslam Boutayeb; Zindoga Mukandavire
Journal:  Int J Environ Res Public Health       Date:  2022-01-10       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.